Quest 10 Wealth Builders, Inc. Gilead Sciences, Inc. Transaction History
Quest 10 Wealth Builders, Inc.
- $93.4 Billion
- Q1 2025
A detailed history of Quest 10 Wealth Builders, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Quest 10 Wealth Builders, Inc. holds 123 shares of GILD stock, worth $13,284. This represents 0.01% of its overall portfolio holdings.
Number of Shares
123
Previous 147
16.33%
Holding current value
$13,284
Previous $13.6 Million
1.36%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.43 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.9 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.78 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...